EMA
guidance
· 2022-08-19
EMA’s Emergency Task Force advises on intradermal use of Imvanex / Jynneos against monkeypox
Summary
EMA’s Emergency Task Force recommends intradermal administration of Imvanex/Jynneos for monkeypox to optimize dose use and supply during outbreaks.
Upgrade for the full analysis, importance score, and drug timeline.